Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing ...

According to the latest study from BCC Research, "Global Colorectal Cancer Screening and Diagnostics Market" is projected to grow from $40.0 billion in 2024 to $46.1 billion by the end of 2029, at a ...

How AI is reshaping biotech through partnerships, from drug discovery to clinical trials, and what it means for the future of ...